Lopinavir/Ritonavir Pharmacokinetics in HIV and Hepatitis C Virus Co-Infected Patients without Liver Function Impairment: Influence of Liver Fibrosis

Author： Moltó José   Valle Marta   Blanco Asunción  

Publisher： Adis International

ISSN： 0312-5963

Source： Clinical Pharmacokinetics, Vol.46, Iss.1, 2007-01, pp. : 85-92

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Highly Active Antiretroviral Therapy on Tacrolimus Pharmacokinetics in Hepatitis C Virus and HIV Co-Infected Liver Transplant Recipients in the ANRS HC-08 Study

By Teicher Elina  

Clinical Pharmacokinetics, Vol. 46, Iss. 11, 2007-01 ,pp. : 941-952

Adis International

Access to resources Recommend Favorite

Therapy of Chronic Hepatitis C Virus Infection in HIV Co-Infected People

By  

Current Pharmaceutical Design, Vol. 10, Iss. 17, 2004-07 ,pp. : 2111-2122

Bentham Science Publishers

Access to resources Recommend Favorite

Non-Invasive Markers of Liver Fibrosis in HCV Mono-Infected and in HIV/HCV Co-Infected Subjects

By  

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 513-519

Bentham Science Publishers

Access to resources Recommend Favorite

Meta-analysis of once-daily and twice-daily lopinavir/ritonavir combined with NRTIs in HIV-1-infected, antiretroviral-naive patients

By van Wyk Jean   Qaqish Roula   Hollar Kimberly   White Kelly   D’’Amico Ronald   Norton Michael   Chiu Yi-Lin   King Martin  

Future Virology, Vol. 7, Iss. 1, 2012-01 ,pp. : 103-113

Future Medicine

Access to resources Recommend Favorite

Darunavir + ritonavir superior to lopinavir/ritonavir for HIV infection

By  

Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite